Reviewed by Roey Hine
Key takeaways
- Neurology billing volume does not guarantee strong collections.
- Time-based E/M documentation gaps delay or reduce reimbursement.
- Prior authorization requirements for EMG, nerve conduction studies, and imaging create cash flow lags.
- Botox and infusion billing errors are a common source of lost revenue.
- Days in A/R and denial patterns reveal where collections break down.
- Practices recover lost revenue through documentation, coding, and process changes.
A neurology practice can run a full schedule and still struggle to collect what it billed. High patient volume does not translate directly into strong cash flow.
Neurology billing carries friction points that other specialties do not face in the same way. Time-based E/M coding, prior authorization for diagnostic testing, and high-cost injectable billing each create opportunities for revenue to stall or disappear.
This post breaks down where neurology practices typically lose collections and what changes recover that revenue.
What Causes Low Collections in Neurology Practices?
Neurology collections typically break down at four points: time-based E/M documentation, prior authorization delays, injectable and infusion billing errors, and inconsistent denial follow-up. Each point interrupts payment differently, but together they compound into a persistent gap between what a practice bills and what it actually collects.
- Time-based E/M coding without documentation to support it
- Prior authorization delays on EMG, nerve conduction studies, imaging, and Botox
- Injectable and infusion billing errors in HCPCS, NDC, or units
- Denials that go unworked past the payer’s appeal window
How Time-Based E/M Coding Affects Neurology Collections
Time-based E/M coding lets a provider select the visit level using total time spent on the date of the encounter, covering chart review, the face-to-face visit, and follow-up work completed before midnight that day. Neurology visits often run long because of complex history review, coordination with other specialists, and counseling on treatment options, but claims get down-coded or denied when the note does not state total time and the activities that filled it.
Documentation needs to record total time and name what filled it: reviewing prior imaging or EMG results, discussing treatment options, coordinating with a headache specialist or physical therapist, or counseling on a new diagnosis. A visit that runs long without this detail in the note still risks being coded and paid at a lower level than the work performed.
Why Prior Authorization Delays Hurt Neurology Cash Flow
Prior authorization delays on EMG, nerve conduction studies, advanced imaging, and Botox for chronic migraine push payment further out and raise the risk of denial if authorization lapses or is submitted with an error. Neurology practices depend on authorization-gated services more than most specialties, which makes these delays a direct threat to cash flow rather than an occasional inconvenience.
- Nerve conduction studies (CPT 95907 through 95913, billed by nerve count) and needle EMG (CPT 95860 through 95870), which often require documented medical necessity beyond the referral
- Advanced imaging such as MRI and CT, which payers frequently gate behind step therapy or prior failed treatment
- Botox for chronic migraine, which most commercial and Medicare Advantage payers gate behind proof of prior therapy failures and periodic reauthorization
How Botox and Infusion Billing Errors Reduce Collections
Botox for chronic migraine bills under CPT 64615 paired with HCPCS J0585, with units reported to match the exact dose administered. Waste is reported separately with modifier JW, and Medicare requires modifier JZ to attest that no waste occurred when the full vial is used. A mismatch between the units billed and the vial size or dosage documented is one of the more common reasons these claims deny or pay incorrectly.
Infusion therapies such as IVIG carry the same risk in a different form: precise HCPCS or J-code selection, NDC reporting, and units billed that match the dosage administered exactly.
Buy-and-bill services add another layer of risk, since the practice has already purchased the drug regardless of whether the claim pays. Getting the code, modifier, and documentation aligned on the first submission matters more here than in most other billing scenarios.
What Days in A/R Reveals About Neurology Collections
Days in A/R measures how long it takes a practice to get paid after a claim is submitted, and a rising number points to a specific breakdown rather than a general sense that billing is slow. In neurology, a climbing days-in-A/R trend most often traces back to authorization delays, time-based coding disputes, or injectable claims stuck in review. Reviewing clean claim rate alongside days in A/R helps separate a submission problem from a payer-side delay.
How Practices Can Improve Neurology Billing Collections
Improving neurology collections comes down to closing the same four gaps consistently: documentation, authorization tracking, injectable billing accuracy, and denial follow-up.
- Build documentation templates that prompt providers to record time-qualifying activities for E/M visits
- Track prior authorization status and expiration dates for EMG, imaging, and Botox separately from general claim status
- Verify injectable units against dosage and NDC before submission
Review common denial patterns on a set schedule instead of only when a denial is already past the appeal window
When Outsourcing Improves Neurology Billing Collections
The biggest collections gains typically come from combining documentation support with dedicated prior authorization tracking, not from chasing individual denials after they have already stalled payment.
An outsourced billing team dedicated to neurology can track authorization status across payers, catch injectable coding errors before submission, and follow up on denials inside the appeal window consistently. If your practice is weighing whether outsourcing makes sense, our neurology billing self-assessment is a good starting point.
If collections are lagging behind your neurology practice’s billed volume, PGM’s neurology billing services are built around the specific points where neurology revenue tends to break down. Reach out to talk through where your practice is losing revenue.
* * *
Frequently Asked Questions About Neurology Billing Collections
What is a good collection rate for a neurology practice?
A strong collection rate is measured against a practice’s own historical baseline and adjusted fee schedule, not a single universal percentage, since payer mix and service mix vary significantly between neurology practices.
How long should neurology prior authorization take?
Timelines vary by payer and by service. EMG and nerve conduction studies, advanced imaging, and Botox for chronic migraine are often reviewed under different criteria and different timelines within the same payer, so tracking each service type separately gives a more accurate picture than tracking prior auth as one category.
Can outsourcing improve collections without changing how providers document visits?
Outsourcing can close some collections gaps, such as authorization tracking and injectable coding accuracy, without any change to provider workflow. Gaps tied to time-based E/M documentation still require provider-side changes, since only the provider can document the time and activities a visit involved.
What is the difference between a denial and an underpayment in neurology billing?
A denial means the payer refused to pay the claim as submitted, usually with a specific reason code. An underpayment means the payer paid the claim but at a lower amount than the contracted rate, which often goes unnoticed because the claim shows as paid rather than as a problem needing follow-up.
How often should a neurology practice review its A/R aging report?
Reviewing A/R aging weekly makes it easier to catch a stalled authorization or an injectable claim stuck in review before it crosses into the range where recovery becomes unlikely.